Although K-Ras-induced lung adenocarcinoma development can proceed via multiple pathways, the frequent inactivation of RUNX3 by epigenetic silencing in K-Ras-induced human lung adenocarcinoma suggests that RUNX3 inactivation prior to K-Ras activation is a major contributing pathway. The gene discussed is RUNX3; the disease is lung adenocarcinoma.